Anne-Françoise Aubry

发表

LC-MS/MS bioanalytical challenge: ultra-high sensitivity assays.

Anne-Françoise Aubry, A. Aubry, 2011, Bioanalysis.

Bioanalysis and where does it fit into the drug development process

Anne-Françoise Aubry, Jim X Shen, Jim X. Shen, 2013 .

A seat at the table: the benefits of integrating bioanalytical sciences into development project teams.

Anne-Françoise Aubry, 2014, Bioanalysis.

Reflecting on a decade of metabolite screening and monitoring.

Jian Wang, Mark E Arnold, Anne-Françoise Aubry, 2014, Bioanalysis.

Conference report: energized bioanalytical solutions at the 2012 Eastern Analytical Symposium & Exposition.

Anne-Françoise Aubry, Ang Liu, 2013, Bioanalysis.

Scientific or regulated validation: a tiered approach? Meeting report from a joint EBF/DVDMDG workshop.

Stuart McDougall, Philip Timmerman, Steve White, 2015, Bioanalysis.

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input).

Lindsay King, Stacy Ho, Roger Hayes, 2014, Bioanalysis.

Conference report: bioanalytical sessions at the 2011 Eastern Analytical Symposium.

Anne-Françoise Aubry, Yue Zhao, Michelle Dawes, 2012, Bioanalysis.

Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.

Jian Wang, Mark E Arnold, Anne-Françoise Aubry, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay.

Hao Jiang, Jianing Zeng, Mark E Arnold, 2012, Analytical chemistry.

A rapid, accurate and robust UHPLC-MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies.

Naiyu Zheng, Jianing Zeng, Yuan-Qing Xia, 2013, Journal of pharmaceutical and biomedical analysis.

Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum.

Hao Jiang, Jianing Zeng, Mark E Arnold, 2013, Analytical chemistry.

A rugged and accurate liquid chromatography-tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma.

Hao Jiang, Jianing Zeng, Yuan-Qing Xia, 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.

Hao Jiang, Jian Wang, Jianing Zeng, 2012, Analytical chemistry.

Simple and efficient digestion of a monoclonal antibody in serum using pellet digestion: comparison with traditional digestion methods in LC-MS/MS bioanalysis.

Long Yuan, Mark E Arnold, Anne-Françoise Aubry, 2012, Bioanalysis.

Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein Biotherapeutics

Surinder Kaur, Jianing Zeng, Faye Vazvaei, 2014, The AAPS Journal.

Improved liquid-liquid extraction with inter-well volume replacement dilution workflow and its application to quantify BMS-927711 in rat dried blood spots by UHPLC-MS/MS.

Naiyu Zheng, Jianing Zeng, Mark E Arnold, 2014, Journal of pharmaceutical and biomedical analysis.

"Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS.

Naiyu Zheng, Jianing Zeng, Yan Song, 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.